181 related articles for article (PubMed ID: 9374099)
1. Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
Seidman AD; Hudis CA; McCaffrey J; Tong W; Currie V; Moynahan ME; Theodoulou M; Tepler I; Gollub M; Norton L
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-72-S17-76. PubMed ID: 9374099
[TBL] [Abstract][Full Text] [Related]
2. Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.
Akerley W; Sikov WM; Cummings F; Safran H; Strenger R; Marchant D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-87-S17-90. PubMed ID: 9374102
[TBL] [Abstract][Full Text] [Related]
3. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
Chang AY; Boros L; Asbury R; Hui L; Rubins J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
[TBL] [Abstract][Full Text] [Related]
4. Salvage weekly paclitaxel in recurrent ovarian cancer.
Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.
Akerley W; Glantz M; Choy H
Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety.
Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M
Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032
[TBL] [Abstract][Full Text] [Related]
8. Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.
Löffler TM; Freund W; Lipke J; Hausamen TU
Semin Oncol; 1996 Dec; 23(6 Suppl 16):32-4. PubMed ID: 9007118
[TBL] [Abstract][Full Text] [Related]
9. Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study.
Köhler U; Olbricht SS; Fuechsel G; Kettner E; Richter B; Ridwelski K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-40-S17-43. PubMed ID: 9374091
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.
Ries F; Duhem C; Kleiber K; Dicato M
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer.
Ford C; Spitzer G; Reilly W; Adkins D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.
Wolf M; Faoro C; Goerg C; Pfab R; Havemann K; Kettner H
Semin Oncol; 1996 Dec; 23(6 Suppl 16):108-12. PubMed ID: 9007135
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
Akerley W
Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123
[TBL] [Abstract][Full Text] [Related]
14. Single-agent paclitaxel for the treatment of breast cancer: an overview.
Hortobagyi GN; Holmes FA
Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.
Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-5-S17-9. PubMed ID: 9374084
[TBL] [Abstract][Full Text] [Related]
16. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
19. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N
Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640
[TBL] [Abstract][Full Text] [Related]
20. [Weekly paclitaxel therapy for metastatic breast cancer].
Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]